Foothill Ventures

For more than a decade, Applied Ventures, LLC - the venture capital arm of Applied Materials - has been turning possibilities into reality by investing in startups with disruptive technologies. Among the innovations we have helped to pioneer are smart phones, argumented and virtual reality (AR and VR), driverless cars, big data, life sciences, robotics, cleantech, and advanced materials. Applied Ventures is stage agnostic and invests up to $100M per year. To date, we have provided capital to more than 90 companies in 17 countries. Why Applied Ventures Matters to Startups Early-stage companies can validate high-performance devices and scale faster as the result of our breakthroughs in materials engineering, semiconductor technology, and our global fab infrastructure. We fast-track our startups’ success by connecting them with global customers, supply chain partners, and co-investors from influential corporate and financial venture capital firms.

Vsquared Ventures backs entrepreneurs engineering the seemingly impossible. We are early-stage investors in deep-tech companies tackling society's most pressing challenges, with an emphasis on quantum and novel computing, green energy, robotics, Al/ML, new space, synthetic biology, and healthcare. Our team of founders, academics, operators and innovators has invested in over 30 companies to date and built one of Europe's strongest deep-tech portfolios, forging alliances with key players in industry, research, and a global startup ecosystem along the way. The companies we've partnered with so far include Isar Aerospace, IOM, Zama, The Exploration Company, and Custom Cells.

A force multiplier for scientists and innovators pushing the boundaries of what’s possible in biology and beyond. We are a team of biologists, engineers, and reformed finance people, but more importantly, we are... Thought partners Builders Optimists Allies We are here to serve our founders, their teams, and the visions they bring to life. Philosophy In the past decade, humanity has gained the ability to Store data on DNA Reprogram cells to kill cancer Train computers to read medical images Write in the code of life Engineer microbes to fix nitrogen for crops What makes all this possible? The Moore meets Mendel moment What it Means We believe we are in the early chapters of a new biological revolution. Data from novel Bio-Tools plus Artificial Intelligence and Machine Learning are generating major new insights in biology. These insights will create the next generation of biological products. And we upend the way we heal, clothe, consume, and protect. Our processThemes: Sydney Brenner said it best: “Progress in science depends on new techniques, new discoveries and new ideas, probably in that order”. As long-time investors in novel data-generation techniques, we are in a privileged position to identify major new themes and big ideas that emerge from this data. We prioritize areas with high potential for 'first-in-class' or 'best-in-class' applications. Research: We dive deep into our core themes, and focus on identifying major unmet needs. OMX has a mature network of founders, colleagues, and researchers who help us every step of the way to find standout companies and ideas. Select + Invest: When we see clear best-in-class solutions with a clear market fit, we invest early and get to work. We strive to earn the right every day by being reachable and generous with time, while at the same time having the technical and detail orientation to be more than a friendly ear. As part of your due diligence on us, we encourage you to reach out to the founders we have partnered with. Who: Anyone, anywhere! Many of the entrepreneurs who we support are first-time founders. For some, this is their third or fourth go round; and for others yet, this is their third or fourth time working with us.

We concentrate on companies that could scale faster with access to our customers, channels, intellectual property, advanced manufacturing capabilities and global presence. We invest in a wide variety of sectors, including those aligned with our businesses. Internet of Things Software & Analytics Materials Science Autonomous Operations Life Sciences Sustainable Solutions

We invest in visionary science start-ups. As part of the xista ecosystem, set up by the Institute of Science and Technology Austria, xista science ventures speak the language of scientist and investor. This makes us a unique partner to fuel founders’ deep tech ideas and help build exciting, scalable companies. Our understanding of academic spin-offs and the deep tech founders landscape, allows xista science ventures to recognise, analyse and propel companies to the next stage. We encourage the cross-fertilisation of startups to inspire new discoveries. Let us learn and profit from each other.

Navigare Ventures is an early-stage investor specialized in science-driven companies. Through our investments, we strengthen the industrial and societal impact of research, as well as the long-term financial capacity of our owners, Wallenberg Investments AB. Our core investment themes within deep tech are underpinned by our knowledge and network in a number of scientific fields and industries. These include advanced computing and quantum technologies, synthetic biology and bio innovation, advanced materials and nano technology as well as data-driven life science. We are long term investors - Seed and Series A and beyond - and form deep and lasting partnerships with founders and entrepreneurs. Our extensive industrial and scientific networks gives us the opportunity to provide capital, network, and know-how to transform promising science start-ups into successful companies. Who we are Navigare Ventures, based in Stockholm, is a fully owned subsidiary of Wallenberg Investments AB. We are a team of scientists, industrialists and entrepreneurs who understand the challenges of turning cutting-edge technologies to successful ventures. As part of the Wallenberg ecosystem, our returns fuel the next generation of scientific advancement through research funding from the Wallenberg Foundations to Swedish universities. What we are looking for We partner with experienced entrepreneurial teams that combine scientific excellence with strong business acumen. In this respect, your company should have a unique offering based on a profound understanding of your scientific or technological field and its market and industrial environment. You should also be capable of demonstrating the viability and commercial potential of your product by engaging with real customers. You are raising capital to scale the R&D, production, marketing, and sales capabilities of your company. Our investment philosophy We only invest in companies we understand. While this is an important general principle in any investment activity, it is even more important when making early-stage investments in new technology. If we don’t understand your science, we won’t understand what experts tell us about the value chain and how it works, or what the competitive landscape looks like. And most importantly, we won’t be able to help you develop your strategy and navigate through the challenges of deep-tech start-ups. So, when preparing a meeting with us, don’t put too much emphasis on future revenue projections. That’s important too, in due time. But first, be prepared for long sessions in front of a whiteboard, explaining to us how your material, algorithm, or antibody functions. We don’t need to understand all the equations, but we need to get the heuristics. We are scientists at heart, eager to learn, and we carry a deep conviction that the world is fundamentally understandable. Core investment themesAdvanced computing and quantum technologies: Digitization and automation deepens in industry and society, driven by breakthroughs in computing and AI. Our focus includes improving existing technologies as well as finding completely new platforms in AI and other areas of applied mathematics as well as in novel computer architectures, communication technology, hardware and design. Synthetic biology and bio innovation: Synthetic biology and bio innovations contribute to a more sustainable society. Companies in this field often combine principles of biology, engineering, and computer science for the development of new biological products and manufacturing methods. Advanced materials and nano technology: New materials and nanoscale technology enable disruptions with the potential to benefit numerous existing industries. From quantum materials to biomaterials and biologically inspired nanostructures, we look for the most promising technology platforms in the field. Data-driven life science: Combining digital technology and data with life science drives scientific understanding and enables novel products. Our focus is on data-driven methods to increase personalization and precision of medical interventions, accelerate product development, digitalize care among other advancements.